Printer Friendly

ICC TECHNOLOGIES COMMENCES TEST OF ITS AIR CONDITIONERS' ABILITY TO DESTROY HARMFUL AIRBORNE MICROORGANISMS AT FOUR MEDICAL FACILITIES

 PHILADELPHIA, Aug. 31 /PRNewswire/ -- ICC Technologies, Inc. (NASDAQ: ICGN) delivered today an ICC air conditioning unit to Hahnemann University's School of Medicine, Philadelphia, which will conduct a series of indoor air quality tests this summer and fall to measure the ability of ICC's air conditioners to reduce the threat of patient infections caused by airborne microorganisms. Air containing ten harmful microorganisms that cause staph infections, pneumonia and other serious ailments at health care facilities will be passed through ICC's DESI/AIR(TM) units, and then analyzed to determine the extent to which these germs are destroyed.
 At the same time, the bacterial cleansing properties of the DESI/AIR units will be tested at three other Eastern Pennsylvania health care facilities -- two hospitals and a nursing home. Under a grant from Ben Franklin Technology Center, samples from all three tests sites will undergo laboratory analysis at Hahnemann and Lehigh University's Center for Molecular Bioscience and Biotechnology.
 Preliminary results from an earlier eight-month study, co-sponsored by ICC and Lehigh University, demonstrated that the DESI/AIR system can reduce by as much as 90 percent the concentration of common airborne microorganisms such as bacteria viruses and mold. The system employed in the Hahnemann test features a newly patented desiccant material developed by Engelhard Corp. that may be even more effective in removing potentially harmful microorganisms. Desiccants, natural or synthetic substances with a high capacity to attract and contain moisture, are in wide use as dehydrating agents.
 Irwin L. Gross, ICC Technologies chairman, said, "We expect the study to confirm DESI/AIR's unique characteristics for treating air in medical facilities. Our new system represents an important breakthrough for millions of hospital and nursing home patients who could face pneumonia and other serious conditions as a result of airborne contaminants. At present, the only means available to control airborne microorganisms within a health care environment is through the use of expensive and elaborate filtration systems."
 ICC Technologies is a leading developer of air conditioning and climate control systems for supermarkets, department stores, health care facilities and other commercial and industrial buildings.
 -0- 8/31/93
 /CONTACT: Albert Resnick, director of ICC Technologies, 215-625-0700/
 (ICGN)


CO: ICC Technologies, Inc. ST: Pennsylvania IN: ENV SU:

WB-PS -- NY033 -- 7521 08/31/93 12:48 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 31, 1993
Words:377
Previous Article:D&F RATES BENEFICIAL STANDARD LIFE INSURANCE COMPANY, GREAT AMERICAN RESERVE INSURANCE COMPANY, JEFFERSON NATIONAL LIFE INSURANCE COMPANY
Next Article:DUFF & PHELPS: CITICORP $350 MILLION PERPETUAL PREFERRED STOCK RATED 'BBB-'
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters